Cargando…

Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients

Background: Antiviral drugs have shown little impact in patient infected with acute respiratory coronavirus 2 (SARS-CoV-2). Especially for immunocompromised persons positive for SARS-CoV-2, novel treatments are warranted. Recently, the U.S. FDA has granted an emergency use authorization (EUA) to two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bachmann, Friederike, Budde, Klemens, Suttorp, Norbert, Lingscheid, Tilman, Stegemann, Miriam Songa, Osmanodja, Bilgin, Schrezenmeier, Eva, Duettmann, Wiebke, Weber, Ulrike, Naik, Marcel, Lehner, Lukas Johannes, Kahl, Andreas, Duerr, Michael, Eckardt, Kai-Uwe, Waiser, Johannes, Choi, Mira, Halleck, Fabian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Health Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008834/ https://www.ncbi.nlm.nih.gov/pubmed/35431640 http://dx.doi.org/10.3389/ti.2022.10109

Ejemplares similares

COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant Center
por: Mikhailov, Michael, et al.
Publicado: (2023)

A single centre in-depth analysis of death with a functioning kidney graft and reasons for overall graft failure
por: Mayrdorfer, Manuel, et al.
Publicado: (2022)

Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions
por: Wu, Kaiyin, et al.
Publicado: (2022)

Evaluation of a clinical decision support system for detection of patients at risk after kidney transplantation
por: Roller, Roland, et al.
Publicado: (2022)

Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment—A Single Center Retrospective Study
por: Wu, Kaiyin, et al.
Publicado: (2021)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
por: López del Moral, Covadonga, et al.
Publicado: (2022)

Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination
por: Ronicke, Simon, et al.
Publicado: (2022)

Risk Factors for Hepatitis E Virus Infection and Eating Habits in Kidney Transplant Recipients
por: Wu, Eva, et al.
Publicado: (2023)

Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center
por: Choi, Mira, et al.
Publicado: (2020)

Impact of COVID-19 on Global Kidney Transplantation Service Delivery: Interim Report
por: Papalois, Vassilios, et al.
Publicado: (2022)

Predictors of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Patients: Baseline Characteristics, Immunosuppression, and the Role of IMPDH Monitoring
por: Liefeldt, Lutz, et al.
Publicado: (2022)

Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients
por: Duerr, Michael, et al.
Publicado: (2020)

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Impact of Early Pancreatic Graft Loss on Outcome after Simultaneous Pancreas–Kidney Transplantation (SPKT)—A Landmark Analysis
por: Lehner, Lukas Johannes, et al.
Publicado: (2021)

A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients
por: Duerr, Michael, et al.
Publicado: (2019)

Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept
por: Choi, Mira, et al.
Publicado: (2020)

The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation
por: Schrezenmeier, Eva, et al.
Publicado: (2021)

Correction to: The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation
por: Schrezenmeier, Eva, et al.
Publicado: (2021)

Absolute or Relative Quantification of Donor-derived Cell-free DNA in Kidney Transplant Recipients: Case Series
por: Osmanodja, Bilgin, et al.
Publicado: (2021)

Pregnancy after Kidney Transplantation—Impact of Functional Renal Reserve, Slope of eGFR before Pregnancy, and Intensity of Immunosuppression on Kidney Function and Maternal Health
por: Kaatz, Rebecca, et al.
Publicado: (2023)

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
por: Schrezenmeier, Eva, et al.
Publicado: (2022)

De-novo malignancies after kidney transplantation: A long-term observational study
por: Fröhlich, Felix A., et al.
Publicado: (2020)

When performance is not enough—A multidisciplinary view on clinical decision support
por: Roller, Roland, et al.
Publicado: (2023)

Clinicopathologic Features and Risk Factors of Proteinuria in Transplant Glomerulopathy
por: Zhang, Qiang, et al.
Publicado: (2021)

Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step
por: Lachmann, Nils, et al.
Publicado: (2017)

Analysis of Risk Factors and Long-Term Outcomes in Kidney Transplant Patients with Identified Lymphoceles
por: Lehner, Lukas J., et al.
Publicado: (2020)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation
por: Akifova, Aylin, et al.
Publicado: (2023)

Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions
por: Tong, Allison, et al.
Publicado: (2022)

Alloimmune Risk Stratification for Kidney Transplant Rejection
por: Bestard, Oriol, et al.
Publicado: (2022)

Influence of Belatacept- vs. CNI-Based Immunosuppression on Vascular Stiffness and Body Composition
por: Heleniak, Zbigniew, et al.
Publicado: (2022)

Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study
por: Osmanodja, Bilgin, et al.
Publicado: (2023)

Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
por: Hilbrands, Luuk, et al.
Publicado: (2022)

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation
por: Seron, Daniel, et al.
Publicado: (2022)

Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation
por: Roufosse, Candice, et al.
Publicado: (2022)

SARS-CoV2 mRNA Vaccine-Specific B-, T- and Humoral Responses in Adolescents After Kidney Transplantation
por: Sattler, Arne, et al.
Publicado: (2022)

Influence of Early Postoperative Basal Insulin Treatment and Post-Transplant Diabetes Mellitus Risk on Health-Related Quality of Life in Kidney Transplant Recipients—An Analysis of Data From a Randomized Controlled Trial
por: Odler, Balazs, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ffil7f45f3nl25t5geh9uif1hg